POH Global Agreement with Novartis Animal Health
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Trading halt
- Preparation- pain patch manufacturing after positive results
- POH Ready to Commence Pivital Oxycodone Clinical Trials
- POH: Phosphagenics - Calzada - Exercise of option
- POH: Anti-fat Peptide Patch progresses
Later from Avecho Biotechnology
- Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne
- Phosphagenics Signs Japanese License Option and R&D Alliance
- Phosphagenics Expands Japanese Option to Oxycodone Patch
- Phosphagenics Expands Licence Agreement for Diclofenac Gel
- Phosphagenics Initiates Cattle Study
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology